Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
11 "Jae Kwan Jun"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original article
Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey (KNCSS), 2005-2020
Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
Epidemiol Health. 2022;e2022111.   Published online November 24, 2022
DOI: https://doi.org/10.4178/epih.e2022111    [Accepted]
  • 957 View
  • 93 Download
AbstractAbstract AbstractSummary PDF
Abstract
Objectives
Since 2002, the Korean government has provided breast cancer screening as part of the National Cancer Screening Program. This study reported the screening rate trends among Korean women from 2005 to 2020, including organized and opportunistic screening for breast cancer.
Methods
Data from the Korean National Cancer Screening Survey, an annual cross-sectional nationwide survey, was collected using a structured questionnaire between 2005 and 2020. The study population included 23,702 women aged 40–74 years with no history of cancer. We estimated the screening rate with the current recommendation of biennial mammographic screening for breast cancer. In addition, a joinpoint trend analysis was performed for breast cancer screening rates using subgroup analysis.
Results
In 2020, the breast cancer screening rate was 63.5%, which showed an annual increase of 7.72% (95% confidence interval 5.53% to 9.95%) between 2005 and 2012, followed by non-significant trends thereafter. In particular, a significant decrease in the breast cancer screening rate was observed in the subgroups aged 50–59 years old, with 12–15 years of education, and living in rural areas.
Conclusions
Although there has been substantial improve in breast cancer screening rates in Korean women, the recent trend has flattened. Therefore, efforts are continually required to find out unmet subgroups and solve barriers for uptake of breast cancer screening.
Summary
Korean summary
본 연구는 2005년에서 2020년까지 암검진수검행태조사 자료를 이용하여 40세 이상의 우리나라 여성의 유방암 검진 수검률이 추이에 대해 분석하였다. 우리나라 유방암 검진 수검률은 2020년 현재 63.5%이다. 하지만 지속적으로 증가하던 유방암 검진 수검률의 추이는 2012년 이후 정체되어 있으며 일부 사회경제적 계층에서는 감소하는 경향을 보였다.
Key Message
In Korea, despite of the high level of breast cancer screening rate, decreasing trends in some socioeconomic classes after 2012. Continual efforts are required to identify subgroup with unmet needs and barriers to the uptake of breast cancer screening.
Systematic review
Non-cancer health risks in firefighters: a systematic review
Jeong Ah Kim, Soo Yeon Song, Wonjeong Jeong, Jae Kwan Jun
Epidemiol Health. 2022;e2022109.   Published online November 16, 2022
DOI: https://doi.org/10.4178/epih.e2022109    [Accepted]
  • 1,264 View
  • 119 Download
AbstractAbstract PDF
Abstract
Firefighters are occupationally exposed to hazardous factors which may increase their risk of disease. Non-cancer disease risk in firefighters has not been systematically examined. This systematic review aimed at identifying non-cancer disease risk in firefighters and determining whether a risk difference exists according to job characteristics. We searched the Cochrane Library, Embase, PubMed, and KoreaMed databases using relevant keywords from their inception to April 30, 2021. The Risk of Bias Assessment Tool for Non-randomized Studies version 2.0 was used to assess the quality of evidence. Because of study heterogeneity, a narrative synthesis was presented. The systematic literature search yielded 2491 studies, of which 66 met the selection and quality criteria. We confirmed that the healthy worker effect is strong in firefighters as compared to the general population. We also displayed a significant increase in the incidence of lumbar disc herniation, lower back pain, angina pectoris, acute myocardial infarction, and post-traumatic stress disorder in firefighters compared to other occupational groups. Contradicting results around PTSD and anxiety disorders risks related to rank were reported. Sufficient evidence for increased risk of lumbar disc herniation, lower back pain, angina pectoris, acute myocardial infarction, and post-traumatic stress disorder was available. There was a difference in the risk of non-cancer disease depending on job type, years of service, and rank. However, caution should be exercised when interpreting the results because the classification criteria for firefighters' jobs and ranks differ by country.
Summary
Korean summary
Key Message
Original Articles
Effect of mammography screening on the long-term survival of breast cancer patients: results from the National Cancer Screening Program in Korea
Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
Epidemiol Health. 2022;44:e2022094.   Published online October 26, 2022
DOI: https://doi.org/10.4178/epih.e2022094
  • 1,382 View
  • 118 Download
AbstractAbstract PDFSupplementary Material
Abstract
OBJECTIVES
This study investigated the effect of mammography screening on the long-term survival of breast cancer (BC) patients aged 40 years or older according to their screening history and duration since screening.
METHODS
The study cohort was organized from 3 nationwide databases of the Korean National Cancer Screening Program, the Korean Central Cancer Registry, and death certificates. We included 24,387 women diagnosed with invasive BC or ductal carcinoma in situ in 2008 and 2009 and followed up until December 31, 2019. Cox proportional-hazards regression was used to investigate the effect of BC screening on the risk of death.
RESULTS
Overall, 20,916 of 24,387 patients (85.8%) were alive at the end of the follow-up period (median: 10.5 years). The long-term survival rate was significantly lower in the never-screened group (80.3%) than in the screened group (88.9%) (p<0.001). A 35% reduction in the risk of BC death (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.60 to 0.70) from screening was observed. A subgroup analysis according to the cancer stage showed 62%, 36%, and 24% lower risks of BC death for the localized stage, regional stage, and distant stage, respectively. Women aged 40-49 years received the least benefit from BC screening (HR, 0.71; 95% CI, 0.62 to 0.81).
CONCLUSIONS
Mammography screening was effective in reducing the risk of BC-specific death in Asian women across all cancer stages. However, this effect was relatively small among women in their 40s, suggesting that more detailed and specialized screening strategies are needed for that age group.
Summary
Korean summary
Key Message
Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea
Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, kyu-won Jung, Myong Cheol Lim, Kui Son Choi
Epidemiol Health. 2022;44:e2022072.   Published online September 7, 2022
DOI: https://doi.org/10.4178/epih.e2022072
  • 1,328 View
  • 73 Download
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
This study aimed to investigate the effect of cervical cancer screening by Papanicolaou (Pap) smears on the long-term survival of cervical cancer patients.
METHODS
We constructed a retrospective cohort of 14,903 women diagnosed with invasive cancer or carcinoma in situ in 2008 and 2009 and followed up until December 31, 2019, by using individual-level data from 3 national databases of the Korean National Cancer Screening Program, the Korean Central Cancer Registry, and death certificates. Cox proportional-hazards regression was used to investigate the effect of cervical cancer screening on mortality.
RESULTS
In total, 12,987 out of 14,867 patients (87.4%) were alive at the end of the follow-up period (median: 10.5 years). Screened patients had a 38% lower risk of cervical cancer death than never-screened patients (hazard ratio [HR], 0.62; 95% confidence interval [CI], 0.54 to 0.70). Screening was associated with 59% and 35% lower risks of death, respectively, in screened patients with localized and regional stages. Furthermore, lower HRs among women who received screening were observed in all age groups, especially women aged 50–59 years (HR, 0.54; 95% CI, 0.42 to 0.69). The lowest HR for cervical cancer death was reported among patients screened within the past 2 years (HR, 0.54; 95% CI, 0.47 to 0.63), and the HRs increased with increasing time intervals.
CONCLUSIONS
Pap smear screening significantly reduced the risk of cervical cancer-specific death in Korean women across all cancer stages.
Summary
Korean summary
한국은 자궁경부암 발생과 사망을 낮추기 위하여 국가암검진사업으로 자궁경부암 검진을 실시하고 있다. 이 연구는 2008-2009년 자궁경부암 진단을 받은 30세-79세 14,903명을 대상으로 과거 자궁경부세포검진 여부에 따른 장기생존율을 추적 조사하였다. 그 결과 자궁경부암 검진을 받은 환자에서 사망 위험비가 약 38% 낮았으며, 2년 이내에 검진을 받은 환자군에서 사망 위험이 가장 낮았다.
Key Message
The Korean National Cancer Screening Program (KNCSP) has provided cervical cancer screening by Pap smear test. However, the survival, particularly long-term survival of cervical cancer patients, has never been evaluated in the KNCSP. This study reports a significant improvement in the long-term survival of screened cervical cancer patients, which persist in subgroup analysis by cancer stage. Patients who were screened within two years before the diagnosis had the best survival.
Changes in cancer screening before and during COVID‐19: findings from the Korean National Cancer Screening Survey 2019 and 2020
Thao Thi Kim Trinh, Yun Yeong Lee, Mina Suh, Jae Kwan Jun, Kui Son Choi
Epidemiol Health. 2022;44:e2022051.   Published online May 30, 2022
DOI: https://doi.org/10.4178/epih.e2022051
  • 5,369 View
  • 342 Download
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The coronavirus disease 2019 (COVID-19) pandemic has negatively affected every aspect of medical care. However, information regarding the impact of the pandemic on cancer screening is lacking. This study aimed to explore cancer screening changes by geographic region before and during the pandemic in Korea.
METHODS
Korean National Cancer Screening Survey data for 2019 and 2020 were used. Changes in the screening rate before and during the COVID-19 pandemic were calculated by subtracting the rate in 2020 from the rate in 2019. Multivariate logistic regression analyses examined the differences in screening rates at the national and 16 provincial levels before and after the COVID-19 outbreak.
RESULTS
The 1-year screening rates for the four types of cancer decreased during the pandemic (stomach cancer: -5.1, colorectal cancer: -3.8, breast cancer: -2.5, cervical cancer: -1.5%p). In metropolitan areas, the odds of undergoing screening tests during the pandemic were significantly lower than before the pandemic for stomach (adjusted odds ratio [aOR], 0.66; 95% confidence interval [CI], 0.56 to 0.76), colorectal (aOR, 0.63; 95% CI, 0.50 to 0.79), and breast cancers (aOR, 0.75; 95% CI, 0.60 to 0.94). Furthermore, the likelihood of undergoing stomach cancer screening during the pandemic was significantly lower than before the pandemic in non-metropolitan urban areas (aOR, 0.81; 95% CI, 0.70 to 0.94), while it was higher in rural areas (aOR, 1.54; 95% CI, 1.10 to 2.16).
CONCLUSIONS
Since the COVID-19 pandemic, the cancer screening rate has decreased significantly, especially in large cities. Public health efforts are required to improve cancer screening rates.
Summary
Korean summary
• 코로나 대유행 이전과 이후의 최근 1년간 암검진 수검률을 비교한 결과, 위암 (5% 포인트), 대장암 (3.8% 포인트), 유방암 (2.5% 포인트), 자궁경부암 (1.5% 포인트) 수검률이 통계적으로 유의하게 감소하였음 • 특히 위암, 대장암, 유방암의 경우 대도시 지역에서의 수검률이 현저하게 감소하였음
Key Message
The 1-year screening rates for stomach, colorectal, breast, and cervical cancer decreased significantly during the pandemic in Korea, especially in large cities.
Effects of a cancer prevention education program on elementary school students’ knowledge, attitude, self-efficacy, and intentions in South Korea
Su Yeon Kye, Soon-Yong Hwang, Kyung Hee Oh, Jae Kwan Jun
Epidemiol Health. 2019;41:e2019027.   Published online June 16, 2019
DOI: https://doi.org/10.4178/epih.e2019027
  • 8,596 View
  • 225 Download
  • 6 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
Most children and adolescents have low levels of cancer knowledge and awareness, and infrequently engage in preventive behaviors. This study examined the effects of a short classroom-based intervention for cancer prevention on knowledge, attitude toward cancer preventability, self-efficacy, and behavioral intentions of fifth-grade elementary school students.
METHODS
The study was based on a pre-post-follow-up, 2-group, quasi-experimental design. Participants in the intervention group attended two 40-minute sessions on cancer prevention education and watched a music video about cancer prevention, while participants in the control group were only exposed to the music video. Self-reported knowledge, attitude toward cancer preventability, self-efficacy, and behavioral intentions were assessed 1 week pre-intervention and post-intervention, as well as 3 months post-intervention.
RESULTS
The 3-month post-intervention results revealed partial effects, indicating that the education intervention improved knowledge and attitudes toward cancer preventability; however, no effects were observed on self-efficacy and behavioral intentions 3 months after the intervention.
CONCLUSIONS
Long-term regular booster sessions are required to improve not only social-cognitive factors, but also behavioral intentions, which could result in behavior changes promoting cancer prevention.
Summary
Korean summary
대부분의 아동과 청소년들은 암예방행동 실천을 잘 하지 못하고 있을뿐만 아니라 낮은 암지식 수준을 보인다. 본 연구는 초등학교 5학년 학생들을 대상으로 단기간의 교실 중심의 암예방중재가 지식, 암예방가능성에 대한 태도, 자기효능감, 행동의도에 미치는 영향을 살펴보았다. 사전-사후-3개월이후 추후조사의 형태로 두 집단 유사실험설계로 구성되었다. 중재집단의 참여자들은 2회의 40분으로 구성된 암예방교육에 참여하였고 암예방뮤직비디오를 시청하였다. 대조집단의 참여자들은 암예방뮤직비디오만 시청하였다. 지식, 암예방가능성에 대한 태도, 자기효능감, 행동의도가 중재전, 중재직후, 중재3개월후에 자가보고형식으로 측정되었다. 3개월 이후 추후조사에서 지식과 암예방가능성에 대한 태도가 향상되었으나, 자기효능감과 행동의도에서는 통계적으로 유의한 차이가 나타나지 않았다. 인지적 요소뿐만 아니라 행동적 요소를 변화하기 위해서는 장기간의 추가교육이 필요할 것으로 판단된다.
Key Message

Citations

Citations to this article as recorded by  
  • Effectiveness of an Educational Program on Awareness of Breast Cancer Risk Factors, Symptoms, and Barriers to Seeking Medical Help among Adolescent Omani School Students—An Interventional Study
    Khadija Al-Hosni, Moon Fai Chan, Mohammed Al-Azri
    Current Oncology.2023; 30(4): 4126.     CrossRef
  • What Children and Adolescents Know and Need to Learn about Cancer
    Carol Sigelman, Imani Jami, Eleanor D’Andria
    The Journal of Genetic Psychology.2022; 183(4): 294.     CrossRef
  • The impact of a breast cancer educational intervention in Ghanaian high schools
    Josephine Nsaful, Florence Dedey, Edmund Nartey, Juliana Labi, Nii Armah Adu-Aryee, Joe Nat Clegg-Lamptey
    BMC Cancer.2022;[Epub]     CrossRef
  • Human genetics education as part of the Japanese Cancer Education Comprehensive Support Project
    Fumi Yamada-Kurebayashi, Motoko Sasaki, Asami Kuga, Risa Kojima, Hidehiko Miyake
    Journal of Community Genetics.2022; 14(2): 163.     CrossRef
  • The Effectiveness of Interventional Cancer Education Programs for School Students Aged 8–19 Years: a Systematic Review
    Khadija Al-Hosni, Moon Fai Chan, Mohammed Al-Azri
    Journal of Cancer Education.2021; 36(2): 229.     CrossRef
  • Adolescents’ Perceptions About Cancer and Preferences for Cancer Education
    Olufunmilola Abraham, Claire A. Rosenberger, Sarah M. LeMay, Sarah J. Bittner
    Cancer Control.2021; 28: 107327482110360.     CrossRef
Physician’s awareness of lung cancer screening and its related medical radiation exposure in Korea
Seri Hong, Suyeon Kim, Mina Suh, Boyoung Park, Kui Son Choi, Jae Kwan Jun
Epidemiol Health. 2018;40:e2018002.   Published online January 20, 2018
DOI: https://doi.org/10.4178/epih.e2018002
  • 11,938 View
  • 254 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
Through a survey on perception of lung cancer screening and accompanying medical radiation exposure in Korea, the present study was to investigate its current situations and evaluate various perception of physicians regarding it in order to propose measures for improvements.
METHODS
Medical specialists in national cancer screening institutions selected through stratified random sampling were subjected to face-to-face interview using a structured questionnaire. We investigated physicians’ perception on effectiveness of lung cancer screening depending on screening modality, selection criteria for subjects of screening, types of equipment used to screen, and perception for seriousness of adverse effects following the test. In addition, odds ratios to underestimate risk of radiation exposure from screening were calculated through logistic regression analysis.
RESULTS
Each response that chest X-ray is effective for lung cancer screening and that smoking history is not considered prior to screening recommendation accounted for more than 60% of respondents, suggesting the chance of unnecessary screening tests. Regarding adverse effects of lung cancer screening, about 85% of respondents replied that false positive, radiation exposure, and overdiagnosis could be ignored. About 70% of respondents underestimated radiation dose from lung cancer screening, and a low proportion of physicians informed patients of radiation exposure risk.
CONCLUSIONS
It was found that most physicians underestimated harms of lung cancer screening including radiation exposure and were lack of awareness regarding lung cancer screening. It should be noted that physicians need to have proper perceptions about screening recommendation and accompanying possible harms, for successful implementation of the screening program.
Summary
Korean summary
전국 100여개 국가암검진 기관을 대상으로 폐암검진 관련 설문을 수행한 결과, 효과적인 폐암검진의 수단이나 방법에 대한 이해 및 검사에 수반되는 각종 부작용에 대한 의사들의 인식이 확연히 부족한 것으로 조사되었다. 그 중에서도 특히 의료방사선 노출에 대한 낮은 인지도는, 촬영 시 피폭량에 대한 전반적인 과소평가 및 방사선 노출 위험과 관련한 환자 교육의 부재를 통해 확인할 수 있었다. 인구집단 대상 선별검사의 도입에 따른 잠재적인 위해 가능성과 그 결과에 대한 고민은 반드시 필요하며, 이와 관련된 의료제공자들의 인식 개선을 촉구하는 본 연구는 정책 도입에 앞서 선결되어야 할 과제로서 공중보건학적 측면에서 중요한 의의를 지닌다.
Key Message

Citations

Citations to this article as recorded by  
  • Why clinicians overtest: development of a thematic framework
    Justin H. Lam, Kristen Pickles, Fiona F. Stanaway, Katy J. L. Bell
    BMC Health Services Research.2020;[Epub]     CrossRef
Factors affecting satisfaction with cancer information provided through the social networking services of the National Cancer Information Center in Korea
Su Yeon Kye, Min Hee Lee, Jisu Yoo, Kyung Hee Oh, Jae Kwan Jun
Epidemiol Health. 2017;39:e2017057.   Published online December 11, 2017
DOI: https://doi.org/10.4178/epih.e2017057
  • 9,157 View
  • 205 Download
  • 3 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
This study aimed to identify the characteristics of social networking service (SNS) users and to assess the relationship of those factors to user satisfaction with the SNSs of the National Cancer Information Center (NCIC) in South Korea.
METHODS
A Web-based survey was completed by 1,670 users of the NCIC SNSs, who provided data on the sources they consulted for information about cancer, determinants of SNS use, sources of NCIC SNS awareness, the time of day they used the SNS, and their satisfaction level.
RESULTS
Facebook users mainly became aware of the NCIC SNSs through an acquaintance’s recommendation, while Twitter was accessed through other SNSs or blogs. Users in their 30s were less satisfied with the NCIC SNSs than those in their teens and 20s. Browsing for cancer-related information on the Internet, prioritizing information quality, and engaging in active use were related to a high level of satisfaction with the NCIC SNSs. Individuals who were exposed to the NCIC SNSs through other SNSs or printed materials were less satisfied with their experience of the NCIC SNSs than those who received a recommendation from an acquaintance.
CONCLUSIONS
These findings may act as a catalyst to guide public health agencies to enhance their use of SNSs.
Summary
Korean summary
본 연구는 소셜네트워크서비스 사용자의 특성을 파악하고 우리나라 국가암정보센터 소셜네트워크서비스 사용자의 만족도에 영향을 주는 요인을 파악하고자 하였다. 국가암정보센터 소셜네트워크서비스 사용자 1,670명을 대상으로 암정보원, 서비스사용동기, 서비스를 알게된 경위, 사용시간대, 서비스 사용 만족도를 조사하였다. 분석결과, 페이스북은 주로 주변 아는 사람들의 권유로 사용하기 시작하였고, 트위터는 다른 사람의 소셜네트워크서비스를 통해 접근하고 있었다. 국가암정보센터에 대한 만족도에 영향을 주는 요인을 살펴보면, 10-20대에 비하여 30대의 만족도가 낮았으며, 인터넷을 통해 암정보를 얻고 있는 경우, 암정보의 질을 중시 여기는 경우, 활발하게 소셜네트워크서비스를 사용하고 있는 경우에 만족도가 높았다. 또한, 다른 사람들의 소셜네트워크서비스나 인쇄물을 통해 국가암정보센터 소셜네트워크서비스를 알게 된 경우 주변 사람들의 권고로 사용하게 된 경우에 비해 만족도가 낮았다. 공공보건의료기관들은 자 기관의 소셜네트워크 서비스 접근도 및 만족도 향상을 위하여 본 결과를 활용할 수 있을 것이다
Key Message

Citations

Citations to this article as recorded by  
  • Association Between Loneliness and the Frequency of Using Online Peer Support Groups Among Cancer Patients With Minor Children: A Cross-Sectional Web-Based Study
    Kazuhiro Kosugi, Yohei Nishiguchi, Tomofumi Miura, Daisuke Fujisawa, Takashi Kawaguchi, Kayo Izumi, Jun Takehana, Yuko Uehara, Yuko Usui, Tatsuto Terada, Yujiro Inoue, Maika Natsume, Midori Yuki Yajima, Yuki Sumazaki Watanabe, Ayumi Okizaki, Eisuke Matsus
    Journal of Pain and Symptom Management.2021; 61(5): 955.     CrossRef
  • Awareness, attitude and barriers of colorectal cancer screening among high-risk populations in China: a cross-sectional study
    Ruo-lin Huang, Qi Liu, Ying-xin Wang, Jin-yu Zou, Li-feng Hu, Wen Wang, Ying-hui Huang, Yi-zhuo Wang, Bo Zeng, Xi Zeng, Ying Zeng
    BMJ Open.2021; 11(7): e045168.     CrossRef
  • Factors affecting online health information seeking by channels
    Su Yeon Kye, Keeho Park
    Korean Journal of Health Education and Promotion.2018; 35(2): 1.     CrossRef
Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
Kumban Walter Chuck, Minji Hwang, Kui Son Choi, Mina Suh, Jae Kwan Jun, Boyoung Park
Epidemiol Health. 2017;39:e2017036.   Published online August 10, 2017
DOI: https://doi.org/10.4178/epih.e2017036
  • 10,493 View
  • 231 Download
  • 13 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
To investigate the screening rates for gastric, breast, and cervical cancer in people with diabetes compared with people without diabetes.
METHODS
Data from the Korea National Health and Nutrition Examination Survey (2007-2009) were used. Cancer-free men who were 40 years old and over and cancer-free women who were 30 years old and over were included. The lifetime screening rate and regular screening rate were compared in people with and without diabetes.
RESULTS
Fewer people with diabetes than people without diabetes had ever received cancer screening (53.5 vs. 59.5%, p<0.001 for gastric cancer; 60.5 vs. 71.5%, p<0.001 for breast cancer; and 49.1 vs. 59.6%, p<0.001 for cervical cancer). Fewer people with diabetes than people without diabetes received the recommended screenings for gastric cancer (38.9 vs. 42.9%, p<0.001), breast cancer (38.8 vs. 44.6%, p<0.001), and cervical cancer (35.1 vs. 51.2%, p<0.001). In subgroup analyses according to socioeconomic factors, the lifetime and recommended screening rates were lower in the diabetic population in most socioeconomic subgroups. In the multivariate analysis adjusted for socioeconomic factors, people with diabetes showed lower lifetime screening rates for gastric and cervical cancer (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7 to 0.9 and OR, 0.7; 95% CI, 0.6 to 0.9), and lower regular screening rates for breast and cervical cancer (OR, 0.7; 95% CI, 0.6 to 0.9 and OR, 0.7; 95% CI, 0.5 to 0.9).
CONCLUSIONS
The cancer screening rate in people with diabetes was lower than in people without diabetes. Considering the higher cancer risk in people with diabetes, efforts to increase the screening rate in this high-risk population should be implemented.
Summary
Korean summary
기존의 여러 연구에서 당뇨병이 있는 사람에서 당뇨병이 없는 경우에 비해 암 발생의 위험이 증가하는 것이 확인되었다. 본 연구에서 당뇨병이 있는 사람과 없는 사람에서 암 수검률을 비교했을 때, 당뇨병이 있는 사람의 위암, 유방암, 자궁경부암의 평생 수검률과 권고안 이행 수검률은 모두 낮았다. 당뇨병 환자가 암 발생의 고위험군임을 고려하였을 때 이들을 대상으로 암 검진 수검률을 높이려는 노력이 필요하다.
Key Message

Citations

Citations to this article as recorded by  
  • Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
    Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
    Annals of Behavioral Medicine.2023; 57(5): 386.     CrossRef
  • Diabetes and Cancer
    Jae Won Hong
    The Journal of Korean Diabetes.2023; 24(1): 12.     CrossRef
  • Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
    Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, Gautier Defossez, Amélie Jamet, Stéphanie Ragot, Marc Paccalin, Samy Hadjadj
    Diabetes & Metabolism.2022; 48(2): 101289.     CrossRef
  • Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms
    Ji‐Bin Li, Keng‐Jian Ke, Wei‐Li Zhang, Ling‐Yan Wang, Yan‐Ping Wu, Fan Weng, Huan Tian, Zhi‐Yu Qiu, Yin Li, Shi‐Yong Lin, Mei‐Xian Ye, Qing‐Jian Ou, Cheng‐Hua Gong, Zhen‐Hai Lu, Zhi‐Zhong Pan, De‐Sen Wan, Jian‐Hong Peng, Yu‐Jing Fang
    Cancer Medicine.2022; 11(22): 4321.     CrossRef
  • Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
    Hans Scherübl
    Zeitschrift für Gastroenterologie.2022;[Epub]     CrossRef
  • Prediction Model for Hypertension and Diabetes Mellitus Using Korean Public Health Examination Data (2002–2017)
    Yong Whi Jeong, Yeojin Jung, Hoyeon Jeong, Ji Hye Huh, Ki-Chul Sung, Jeong-Hun Shin, Hyeon Chang Kim, Jang Young Kim, Dae Ryong Kang
    Diagnostics.2022; 12(8): 1967.     CrossRef
  • Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
    Hans Scherübl
    Diabetes aktuell.2022; 20(06): 287.     CrossRef
  • The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng
    Biomolecules.2021; 11(7): 1022.     CrossRef
  • Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing
    Christian von Wagner, Dorina Cadar, Ruth A Hackett, Panayotes Demakakos, Rebecca J Beeken, Stacy Cooper Bailey, Michael Wolf, Andrew Steptoe, Cristina Renzi, Sandro T Stoffel
    Journal of Medical Screening.2020; 27(1): 25.     CrossRef
  • Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
    Dominika Bhatia, Iliana C. Lega, Wei Wu, Lorraine L. Lipscombe
    Diabetologia.2020; 63(1): 34.     CrossRef
  • Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
    Iliana C Lega, Lorraine L Lipscombe
    Endocrine Reviews.2020; 41(1): 33.     CrossRef
  • The Incidences and Characteristics of Various Cancers in Patients on Dialysis: a Korean Nationwide Study
    Soon Kil Kwon, Joung-Ho Han, Hye-Young Kim, Gilwon Kang, Minseok Kang, Yeonkook J. Kim, Jinsoo Min
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
    Sunghwan Suh, Kwang-Won Kim
    Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries
Eunji Choi, Sangeun Lee, Bui Cam Nhung, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi
Epidemiol Health. 2017;39:e2017006.   Published online February 5, 2017
DOI: https://doi.org/10.4178/epih.e2017006
  • 14,685 View
  • 425 Download
  • 57 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
Assessing long-term success and efficiency is an essential part of evaluating cancer control programs. The mortality-to-incidence ratio (MIR) can serve as an insightful indicator of cancer management outcomes for individual nations. By calculating MIRs for the top five cancers in Organization for Economic Cooperation and Development (OECD) countries, the current study attempted to characterize the outcomes of national cancer management policies according to the health system ranking of each country.
METHODS
The MIRs for the five most burdensome cancers globally (lung, colorectal, prostate, stomach, and breast) were calculated for all 34 OECD countries using 2012 GLOBOCAN incidence and mortality statistics. Health system rankings reported by the World Health Organization in 2000 were updated with relevant information when possible. A linear regression model was created, using MIRs as the dependent variable and health system rankings as the independent variable.
RESULTS
The linear relationships between MIRs and health system rankings for the five cancers were significant, with coefficients of determination ranging from 49 to 75% when outliers were excluded. A clear outlier, Korea reported lower-than-predicted MIRs for stomach and colorectal cancer, reflecting its strong national cancer control policies, especially cancer screening.
CONCLUSIONS
The MIR was found to be a practical measure for evaluating the long-term success of cancer surveillance and the efficacy of cancer control programs, especially cancer screening. Extending the use of MIRs to evaluate other cancers may also prove useful.
Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study
    Abolfazl Avan, Vladimir Hachinski
    Alzheimer's & Dementia.2023; 19(4): 1281.     CrossRef
  • Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures
    Chang-Cheng Su, Brian-Shiian Chen, Hsin-Hung Chen, Wen-Wei Sung, Chi-Chih Wang, Ming-Chang Tsai
    Healthcare.2023; 11(2): 159.     CrossRef
  • Updated epidemiology of gastrointestinal cancers in East Asia
    Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
    Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271.     CrossRef
  • Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery
    Vijay Bhooshan Kumar, Busra Ozguney, Anastasia Vlachou, Yu Chen, Ehud Gazit, Phanourios Tamamis
    The Journal of Physical Chemistry B.2023; 127(9): 1857.     CrossRef
  • Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019
    Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li, Xian‐Tao Zeng
    The Prostate.2022; 82(2): 193.     CrossRef
  • Cancer of unknown primary ‐ incidence, mortality trend, and mortality‐to‐incidence ratio is associated with human development index in Central Serbia, 1999–2018: Evidence from the national cancer registry
    Aleksandra Ignjatović, Miodrag Stojanović, Zoran Milošević, Marija Anđelković Apostolović, Tamara Filipović, Nataša Rančić, Roberta Marković, Marija Topalović, Dijana Stojanović, Suzana Otašević
    European Journal of Cancer Care.2022;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019
    Sara Momtazmanesh, Sahar Saeedi Moghaddam, Elaheh Malakan Rad, Sina Azadnajafabad, Narges Ebrahimi, Esmaeil Mohammadi, Mahtab Rouhifard, Negar Rezaei, Masoud Masinaei, Nazila Rezaei, Mohammad Keykhaei, Arya Aminorroaya, Azin Ghamari, Bagher Larijani, Fars
    European Journal of Preventive Cardiology.2022; 29(8): 1287.     CrossRef
  • Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
    Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi
    BMC Public Health.2022;[Epub]     CrossRef
  • Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020
    Rajesh Sharma, Aashima, Mehak Nanda, Claudio Fronterre, Paul Sewagudde, Anna E. Ssentongo, Kelsey Yenney, Nina D. Arhin, John Oh, Forster Amponsah-Manu, Paddy Ssentongo
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
    Freddie Bray, D Maxwell Parkin, Freddy Gnangnon, Gontse Tshisimogo, Jean-Felix Peko, Innocent Adoubi, Mathewos Assefa, Lamin Bojang, Baffour Awuah, Moussa Koulibaly, Nathan Buziba, Anne Korir, Charles Dzamalala, Bakarou Kamate, Shyam Manraj, Josefo Ferro,
    The Lancet Oncology.2022; 23(6): 719.     CrossRef
  • Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
    Shahnaz Esmaeili, Sahar Saeedi Moghaddam, Nazli Namazi, Fatemeh Bandarian, Zahra Esfahani, Maryam Peimani, Sarvenaz Shahin, Ensieh Nasli-Esfahani, Isa Akbarzadeh, Ali Ghanbari, Negar Rezaei, Nazila Rezaei, Bagher Larijani, Farshad Farzadfar
    Diabetes Research and Clinical Practice.2022; 188: 109912.     CrossRef
  • Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative
    Baohua Wang, Fengdie He, Yanan Hu, Qiutong Wang, Dan Wang, Yuting Sha, Jing Wu
    BMC Cancer.2022;[Epub]     CrossRef
  • Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review
    Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay
    Kidney Cancer.2022; 6(2): 129.     CrossRef
  • Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies
    Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi
    Life Cycle.2022;[Epub]     CrossRef
  • Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
    Mohsen Abbasi-Kangevari, Naser Ahmadi, Nima Fattahi, Negar Rezaei, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zahra Esfahani, Ali-Asghar Kolahi, Shahin Roshani, Sahba Rezazadeh-Khadem, Fateme Gorgani, Seyyed
    PLOS ONE.2022; 17(8): e0271284.     CrossRef
  • A scoping review on population-centered indicators for cancer care continuum
    Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • COMPARISON OF TEMPORAL TRENDS IN THE GLOBAL BURDEN OF TRACHEA, BRONCHIAL, AND LUNG CANCER
    İskender ÇETİNTÜRK, Vahit YİĞİT
    Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi.2022; 8(2): 254.     CrossRef
  • ANALYSIS OF INCIDENCE AND MORTALITY OF GASTROINTESTINAL MALIGNANT TUMORS IN UKRAINE AND WORLDWIDE
    Valeriy Zub
    Acta Medica Leopoliensia.2022; 28(3-4): 22.     CrossRef
  • Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Breast Cancer Research and Treatment.2021; 187(2): 557.     CrossRef
  • A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
    Mohammad Keykhaei, Masood Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi-Kangevari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Far
    Experimental Hematology & Oncology.2021;[Epub]     CrossRef
  • The global landscape of drug development of trastuzumab biosimilars
    Dario Trapani, Giuseppe Curigliano
    Journal of Cancer Policy.2021; 28: 100273.     CrossRef
  • Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
    Maedeh Amini, Farid Zayeri, Masoud Salehi
    BMC Public Health.2021;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
    Sina Azadnajafabad, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Negar Rezaei, Erfan Ghasemi, Nima Fattahi, Arya Aminorroaya, Reza Azadnajafabad, Armin Aryannejad, Nazila Rezaei, Shohreh Naderimagham, Vahid Haghpanah, Ali H. Mokdad, Hossein Gharib, Farshad
    Cancer Medicine.2021; 10(7): 2496.     CrossRef
  • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990
    Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Honey and its protein components: Effects in the cancer immunology
    Ivan Chan‐Zapata, Maira Rubí Segura‐Campos
    Journal of Food Biochemistry.2021;[Epub]     CrossRef
  • A Comparison of the United States and Austrian Healthcare Needs and Systems
    Margaret McAlister, Joey D. Helton
    INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021; 58: 004695802110001.     CrossRef
  • Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
    Jasmine Lim, Mizuki Onozawa, Marniza Saad, Teng Aik Ong, Rohan Malek, Hideyuki Akaza
    Cancer Science.2021; 112(6): 2071.     CrossRef
  • A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015
    Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Gowtham Rao, Charles L. Bennett, Christopher T. Emrich, Kathlyn S. Haddock, James R. Hébert
    Annals of Epidemiology.2021; 59: 24.     CrossRef
  • Assessment of quality benchmarks in adenoma detection in Mexico
    Nancy E. Aguilar-Olivos, Ricardo Balanzá, Fernando Rojas-Mendoza, Rodrigo Soto-Solis, Mario A. Ballesteros-Amozurrutia, Norma González-Uribe, Justo A. Fernández-Rivero
    Endoscopy International Open.2021; 09(06): E796.     CrossRef
  • Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health
    Wen-Wei Sung, Yong-Chen Hsu, Chen Dong, Ying-Ching Chen, Yu-Chi Chao, Chih-Jung Chen
    International Journal of Environmental Research and Public Health.2021; 18(11): 6012.     CrossRef
  • In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
    Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim
    Egyptian Journal of Radiology and Nuclear Medicine.2021;[Epub]     CrossRef
  • Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
    Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis
    Tlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, Dumelang Legobere, Warona S. Motlhwa, Anthony A. Oyekunle, Surbhi Grover, Frances K. Barg, Lawrence N. Shulman, Yehoda M. Martei
    The Oncologist.2021; 26(12): e2200.     CrossRef
  • Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
    Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Angéla Benedek, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea Dániel, Kata Knollmajer, György Rokszin, Ibolya Fábián, Zsófia Barcza, Csaba Polg
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Cancer survival status among male population of Northeast India: A hospital based study
    Manoj Kalita, JagannathDev Sharma, Debanjana Barman, Nizara Baishya, ChandiRam Kalita
    Annals of Oncology Research and Therapy.2021; 1(1): 28.     CrossRef
  • Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
    Rolvix H. Patterson, Victoria G. Fischman, Isaac Wasserman, Jennifer Siu, Mark G. Shrime, Johannes J. Fagan, Wayne Koch, Blake C. Alkire
    Otolaryngology–Head and Neck Surgery.2020; 162(3): 296.     CrossRef
  • Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016
    Mahsima Shabani, Sahar Saeedi Moghaddam, Bahar Ataeinia, Nazila Rezaei, Farnam Mohebi, Bahram Mohajer, Kimiya Gohari, Ali Sheidaei, Farhad Pishgar, Moein Yoosefi, Farzad Kompani, Farshad Farzadfar
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice
    Maha Abdulrahman Aldubayan
    BioMed Research International.2020; 2020: 1.     CrossRef
  • The economic burden of cancer care for Syrian refugees: a population-based modelling study
    Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan
    The Lancet Oncology.2020; 21(5): 637.     CrossRef
  • Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
    Heinz Ludwig, Susie Novis Durie, Angela Meckl, Axel Hinke, Brian Durie
    The Oncologist.2020; 25(9): e1406.     CrossRef
  • Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Japanese Journal of Clinical Oncology.2020; 50(12): 1370.     CrossRef
  • Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis
    Jason Semprini, Olufunmilayo Olopade
    JCO Global Oncology.2020; (6): 1178.     CrossRef
  • State-Level Disparity in Lung Cancer Survival in the United States
    Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Inequalities in the burden of female breast cancer in Brazil, 1990–2017
    Maximiliano Ribeiro Guerra, Mário Círio Nogueira, Deborah Carvalho Malta, Camila Soares Lima Côrrea, Maria de Fatima Marinho de Souza, Maria Paula Curado, Mariana Santos Felisbino-Mendes, Meghan Mooney, Mohsen Naghavi, Maria Teresa Bustamante-Teixeira
    Population Health Metrics.2020;[Epub]     CrossRef
  • Disparities in mortality‐to‐incidence ratios by race/ethnicity for female breast cancer in New York City, 2002‐2016
    Tamar B. Nobel, Charles K. Asumeng, John Jasek, Kellie C. Van Beck, Ruchi Mathur, Baozhen Qiao, Jennifer J. Brown
    Cancer Medicine.2020; 9(21): 8226.     CrossRef
  • Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles
    Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-hua Jiang, Ling Wang, Huile Gao
    Nano Letters.2020; 20(12): 8903.     CrossRef
  • Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application
    Girolamo Ranieri, Mariarita Laforgia, Patrizia Nardulli, Simona Ferraiuolo, Pasquale Molinari, Ilaria Marech, Cosmo Damiano Gadaleta
    Cancers.2019; 11(2): 141.     CrossRef
  • Melanoma prognosis in the United States: Identifying barriers for improved care
    Zachary H. Hopkins, Christopher Moreno, Ryan Carlisle, Aaron M. Secrest
    Journal of the American Academy of Dermatology.2019; 80(5): 1256.     CrossRef
  • The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
    Erik Ladomersky, Denise M. Scholtens, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Bin Zhang, Rimas V. Lukas, Derek A. Wainwright
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival
    Libby Ellis, Aurélien Belot, Bernard Rachet, Michel P. Coleman
    Journal of Global Oncology.2019; (5): 1.     CrossRef
  • National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014)
    Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Ali Ghanbari Motlagh, Gholamreza Roshandel, Maryam Nouri, Mohammad Esmaeil Akbari
    International Journal of Cancer Management.2019;[Epub]     CrossRef
  • The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers
    Lee, Sung, Chan, Lee, Chen, Huang, Kwan
    International Journal of Environmental Research and Public Health.2019; 16(15): 2739.     CrossRef
  • miR‐181a/b therapy in lung cancer: reality or myth?
    Cornelia Braicu, Diana Gulei, Roxana Cojocneanu, Lajos Raduly, Ancuta Jurj, Erik Knutsen, George Adrian Calin, Ioana Berindan‐Neagoe
    Molecular Oncology.2019; 13(1): 9.     CrossRef
  • Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems
    Dario Trapani, Giuseppe Curigliano, Alexandru Eniu
    Breast Care.2019; 14(6): 373.     CrossRef
  • Epidemiology of prostate cancer in Asian countries
    Takahiro Kimura, Shin Egawa
    International Journal of Urology.2018; 25(6): 524.     CrossRef
  • Cause-of-death statistics in 2016 in the Republic of Korea
    Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
  • Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries
    Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung
    BMJ Open.2018; 8(7): e020618.     CrossRef
Mortality Trends in Colorectal Cancer and Breast Cancer in Korea: Birth Cohort Effects?.
Jae Kwan Jun, Yeon Ju Kim, Jin Gwack, Yunhee Choi, Yun Chul Hong, Keun Young Yoo
Korean J Epidemiol. 2005;27(1):154-162.
  • 65,535 View
  • 34 Download
AbstractAbstract PDF
Abstract
PURPOSE
Cancer has been the leading cause of deaths since 1980s in Korea. Among them, colorectal cancer and breast cancer shows steadily increasing pattern, being the fourth and the fifth common site of cancer death in Korea, respectively. This analysis aimed to evaluate potential contribution of birth cohort effects to the recent increases in mortality of colorectal cancer and breast cancer since 1983 in Korea.
METHODS
Mortality statistics on deaths of both cancers for the past 20 years of 1983~2002 were obtained from the National Statistical Office. The age-standardized mortality rates were calculated based on the census population of 1992 as a standard.
RESULTS
Age-standardized mortality rate for colorectal cancer increased 4.7-fold in men and 3.6-fold in women, whereas 2.1-fold increase in breast cancer mortality during 1983~2002. Age-specific mortality rates for colorectal cancer were steadily increasing by age before 1991 in both genders. However, the mortality rates showed an exponentially increasing pattern for the age group of 70 and over during 1993~2001, which was more prominent in female. The birth cohort curves showed that there were 2- to 3-fold increases in the mortality rates of people who were born in 1931 for colorectal cancer compared to those of people who were born in 1921. Differences in mortality for breast cancer by birth cohort were 1.7-fold among age group of 45~49 and 50~54 between 1936 and 1946.
CONCLUSIONS
This analysis suggests that recent increases in mortality of colorectal cancer and breast cancer could potentially be due to birth cohort effects, i.e. rapid changes in life-style in younger generation. The quantitative approach using age-period-cohort model should be pursued.
Summary
Korean summary
Key Message

Epidemiol Health : Epidemiology and Health